Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05090839
Other study ID # 20190760
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 18, 2021
Est. completion date December 2, 2023

Study information

Verified date February 2024
Source University of Miami
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test if expressive writing about traumatic events has positive changes in women living with post-traumatic stress.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 2, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender Female
Age group 21 Years and older
Eligibility Inclusion Criteria: 1. Age = 21 years 2. Elevated PTSD symptoms as assessed by the Post-Traumatic Stress Disorder Checklist Scale-Version DSM 5 (PCL-5) using a cut-off of 34 or above 3. On a stable anti-retroviral therapy regimen for > 6 months as assessed with the Adult AIDS Clinical Trial Group structured interview 4. Spanish-English bilingual as measured by the Brief Acculturation Scale for Hispanics (cut-off of 3), Spanish speaker or English speaker 5. Participant is willing and able to sign Informed Consent Form (ICF) 6. self-report as Latina 7. HIV positive serostatus as determined by medical record within the last 12 months 8. Born female. Exclusion Criteria: 1. Left-handedness or ambidextrous 2. Inability to tolerate the scanning procedures 3. Metal in body or prior history working with metal fragments 4. Any other contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body) 5. currently pregnant or could be pregnant 6. Heavy alcohol intake (> 3 drinks) within 12 hours prior to participation in Functional Magnetic Resonance Imaging (fMRI) 7. Evidence from health history of neurological or systemic disorder which can cause cognitive impairment 8. Self-reported current diagnosis of psychiatric disorder or psychoactive substance abuse or dependence 9. Recent history (within two years) of myocardial infarction 10. Severe cardiovascular disease, or currently active cardiovascular disease (e.g., angina, cardiomyopathy) 11. Uncontrolled hypertension or hypotension 12. History of closed trauma with loss of consciousness 13. Space occupying lesions (e.g., mass lesions, tumors) 14. Central Nervous System (CNS) infection 15. CNS vasculitis 16. CNS demyelinating disease (e.g., multiple sclerosis) 17. Congenital CNS abnormality (e.g., cerebral palsy) 18. Seizure disorders 19. History of cerebrovascular disease (e.g., stroke, TIA's)

Study Design


Intervention

Behavioral:
Weekly Emotional Disclosure (WED)
Online writing session with each session lasting approximately 30 minutes. Participants will be instructed to write about either a major traumatic life experience or what the participant did the previous day.

Locations

Country Name City State
United States University of Miami Miami Florida

Sponsors (2)

Lead Sponsor Collaborator
University of Miami Center for Latino Health Research Opportunities

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in PTSD symptoms as assessed by the Impact of Event Scale and/or the PCL5 Post Traumatic Stress Disorder (PTSD) symptoms will be assessed via the Impact of Event Scale (IES). IES is a 22-item self-report instrument that corresponds to Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of PTSD over last 7 days. The IES has a total score ranging from 0 to 88 with the higher score indicating greater PTSD symptoms. Baseline, 6 weeks
Primary Assess change in gene expression for FKBP5, NFkB, & CTRA Assess changes in whole blood RNA expression of genes which code for HPA-axis activity (FKBPG), pro-inflammatory response (NFkB), and conserved transcriptional response to adversity (CTRA). Baseline, 6 weeks
Secondary Changes in limbic system response to traumatic memory recall & verbal learning & recall. Change in BOLD response of ventromedial prefrontal cortex, amygdala, and hippocampus (regions involved in emotion and memory). Activity indexed by Fisher's Z or Beta wt using fMRI for the trauma recall task and verbal learning and memory task before and after the intervention. Baseline, 6 weeks
Secondary Change in salivary alpha amylase (sAA) levels & change in salivary adrenal corticotrophin releasing hormone (ACTH) levels As assessed from saliva samples Baseline, 6 weeks
Secondary Change in dexamethasone suppression of peripheral mononuclear cells. Assessed from peripheral blood, the propensity for immune cells to release pro-inflammatory cytokines in response to LPS stimulation. Baseline, 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT05934162 - Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD N/A
Recruiting NCT05934175 - Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder N/A
Completed NCT04460014 - Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Active, not recruiting NCT05992649 - The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Not yet recruiting NCT05331534 - Effect of Attentional Therapy on Post-traumatic Stress Disorder N/A
Not yet recruiting NCT03649607 - Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black N/A
Not yet recruiting NCT04076215 - Biochemical and Physiological Response to Stressogenic Stimuli N/A
Not yet recruiting NCT02545192 - A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments Phase 1
Completed NCT02329418 - Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit N/A
Active, not recruiting NCT00978484 - A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Phase 3
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03278171 - Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
Recruiting NCT05874362 - People Bereaved by Violent Death : Negative Event Biases and Temporal Perception N/A
Terminated NCT03898843 - Assisted Animal Therapy: ReAnimal N/A
Recruiting NCT04747379 - Psychological Effect of Explicit Recall After Sedation (PEERS)
Completed NCT03248167 - Cannabidiol as a Treatment for AUD Comorbid With PTSD Phase 1/Phase 2